Alison D. Augustine

ORCID: 0000-0003-0064-9785
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Mosquito-borne diseases and control
  • Malaria Research and Control
  • Biomedical Text Mining and Ontologies
  • Bioinformatics and Genomic Networks
  • Immune responses and vaccinations
  • Effects of Radiation Exposure
  • Genomics and Rare Diseases
  • Respiratory viral infections research
  • vaccines and immunoinformatics approaches
  • Tryptophan and brain disorders
  • interferon and immune responses
  • Complement system in diseases
  • Biochemical effects in animals
  • Monoclonal and Polyclonal Antibodies Research
  • Viral Infections and Outbreaks Research
  • Influenza Virus Research Studies
  • Viral Infections and Vectors
  • Invertebrate Immune Response Mechanisms
  • Spaceflight effects on biology
  • Adipokines, Inflammation, and Metabolic Diseases
  • Cell Image Analysis Techniques
  • Vaccine Coverage and Hesitancy

National Institute of Allergy and Infectious Diseases
2010-2025

National Institutes of Health
2009-2025

National Institute of Infectious Diseases
2023

A priority for the National Institute of Allergy and Infectious Diseases is development a universal influenza vaccine providing durable protection against multiple strains. NIAID will use this strategic plan as foundation future investments in research.

10.1093/infdis/jiy103 article EN public-domain The Journal of Infectious Diseases 2018-02-21

Aging | doi:10.18632/aging.100531. T. Kevin Howcroft, Judith Campisi, Germaine Buck Louis, Martyn Smith, Bradley Wise, Tony Wyss-Coray, Alison Deckhut Augustine, Janet E. McElhaney, Ron Kohanski, Felipe Sierra

10.18632/aging.100531 article EN cc-by Aging 2013-01-30
Al Ozonoff Joanna Schaenman Naresh Doni Jayavelu Carly E. Milliren Carolyn S. Calfee and 95 more Charles B. Cairns Monica Kraft Lindsey R. Baden Albert C. Shaw Florian Krammer Harm van Bakel Denise Esserman Shanshan Liu Ana Fernandez Sesma Viviana Simon David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Ofer Levy Christian Bime Elias K. Haddad David J. Erle Bali Pulendran Kari C. Nadeau Mark M. Davis Catherine L. Hough William B. Messer Nelson Iván Agudelo Higuita Jordan P. Metcalf Mark A. Atkinson Scott C. Brakenridge David B. Corry Farrah Kheradmand Lauren I. R. Ehrlich Esther Melamed Grace A. McComsey Rafick‐Pierre Sékaly Joann Diray‐Arce Bjoern Peters Alison D. Augustine Elaine F. Reed Matthew C. Altman Patrice M. Becker Nadine Rouphael Al Ozonoff Joanna Schaenman Naresh Doni Jayavelu Carly E. Milliren Carolyn S. Calfee Charles B. Cairns Monica Kraft Lindsey R. Baden Albert C. Shaw Florian Krammer Harm van Bakel Denise Esserman Shanshan Liu Ana Fernandez Sesma Viviana Simon David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Ofer Levy Chris Bime Elias K. Haddad David J. Erle Bali Pulendran Kari C. Nadeau Mark M. Davis Catherine L. Hough William B. Messer Nelson Iván Agudelo Higuita Jordan P. Metcalf Mark A. Atkinson Scott C. Brakenridge David B. Corry Farrah Kheradmand Lauren I. R. Ehrlich Esther Melamed Grace A. McComsey Rafick‐Pierre Sékaly Joann Diray‐Arce Bjoern Peters Alison D. Augustine Elaine F. Reed Kerry McEnaney Brenda Barton Claudia Lentucci Mehmet Saluvan Ana C. Chang Annmarie Hoch Albert Marisa Tanzia Shaheen Alvin T. Kho Sanya Thomas Jing Chen Maimouna D. Murphy Mitchell Cooney Scott Presnell Gabriela K. Fragiadakis

Better understanding of the association between characteristics patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management.

10.1016/j.ebiom.2022.104208 article EN cc-by-nc-nd EBioMedicine 2022-08-09
Joann Diray‐Arce Slim Fourati Naresh Doni Jayavelu Ravi K. Patel Cole Maguire and 95 more Ana C. Chang Ravi Dandekar Jingjing Qi Brian H. Lee Patrick van Zalm Andrew Schroeder Ernie Chen Anna Konstorum Anderson F. Brito Jeremy P. Gygi Alvin T. Kho Jing Chen Shrikant Pawar Ana S. González-Reiche Annmarie Hoch Carly E. Milliren James A. Overton Kerstin Westendorf Charles B. Cairns Nadine Rouphael Steven E. Bosinger Seunghee Kim‐Schulze Florian Krammer Lindsey B. Rosen Nathan D. Grubaugh Harm van Bakel Michael R. Wilson Jayant V. Rajan Hanno Steen Walter L. Eckalbar Chris Cotsapas Charles Langelier Ofer Levy Matthew C. Altman Holden T. Maecker Ruth R. Montgomery Elias K. Haddad Rafick‐Pierre Sékaly Denise Esserman Al Ozonoff Patrice M. Becker Alison D. Augustine Leying Guan Bjoern Peters Steven H. Kleinstein James Abraham Michael Adkisson Albert Marisa Luz Torres Altamirano Bonny D. Alvarenga Matthew L. Anderson Evan J. Anderson Azlann Arnett Hiromitsu Asashima Mark A. Atkinson Lindsey R. Baden Brenda Barton Katherine F. Beach Elizabeth Beagle Patrice M. Becker Matthew R. Bell Mariana Bernui Christian Bime Arun K. Boddapati J. Leland Booth Brittney Borresen Scott C. Brakenridge Laurel Bristow Robert W. Bryant Carolyn S. Calfee Juan Manuel Carreño Sidney Carrillo Suzanna Chak Iris Chang Jennifer Connors Michelle Conway David B. Corry David Cowan Brett Croen Charles S. Dela Cruz Gina Cusimano Lily Eaker Carolyn Pope Edwards Lauren I. R. Ehrlich David Elashoff Heidi L. Erickson David J. Erle Shelli Farhadian Keith Farrugia Benoit Fatou Andrea Fernandes Ana Fernandez‐Sesma Gabriela K. Fragiadakis Sara Furukawa Janelle Geltman

The IMPACC cohort, composed of >1,000 hospitalized COVID-19 participants, contains five illness trajectory groups (TGs) during acute infection (first 28 days), ranging from milder (TG1–3) to more severe disease course (TG4) and death (TG5). Here, we report deep immunophenotyping, profiling >15,000 longitudinal blood nasal samples 540 participants the using 14 distinct assays. These unbiased analyses identify cellular molecular signatures present within 72 h hospital admission that...

10.1016/j.xcrm.2023.101079 article EN cc-by Cell Reports Medicine 2023-05-23
Benjamin Haslund-Gourley Kyra Woloszczuk Jintong Hou Jennifer Connors Gina Cusimano and 95 more Matthew R. Bell Bhavani Taramangalam Slim Fourati Nathan Mege Mariana Bernui Matthew C. Altman Florian Krammer Harm van Bakel Al Ozonoff Lauren I. R. Ehrlich Esther Melamed Ana Fernandez‐Sesma Viviana Simon Bali Pulendran Kari C. Nadeau Mark M. Davis Grace A. McCoey Rafick‐Pierre Sékaly Lindsey R. Baden Ofer Levy Joanna Schaenman Elaine F. Reed Albert C. Shaw David A. Hafler Ruth R. Montgomery Steven H. Kleinstein Patrice M. Becker Alison D. Augustine Carolyn S. Calfee David J. Erle Michael E. DeBakey David B. Corry Farrah Kheradmand Mark A. Atkinson Scott C. Brakenridge Nelson Iván Agudelo Higuita Jordan P. Metcalf Catherine L. Hough William B. Messer Monica Kraft Chris Bime Bjoern Peters Carly E. Milliren Caitlin Syphurs Kerry McEnaney Brenda Barton Claudia Lentucci Mehmet Saluvan Ana C. Chang Annmarie Hoch Albert Marisa Tanzia Shaheen Alvin T. Kho Shanshan Liu Sanya Thomas Jing Chen Maimouna D. Murphy Mitchell Cooney Arash Nemati Hayati Robert W. Bryant James Abraham Naresh Doni Jayavelu Scott Presnell Tomasz Jancsyk Cole Maguire Jingjing Qi Brian Lee Slim Fourati Denise Esserman Leying Guan Jeremy P. Gygi Shrikant Pawar Anderson F. Brito Gabriela K. Fragiadakis Ravi K. Patel James A. Overton Randi Vita Kerstin Westendorf Casey P. Shannon Scott J. Tebbutt Rama Thyagarajan Justin F. Rousseau Dennis Wylie Todd Triplett Erna Milunka Kojic R. Sharon Chinthrajah Neera Ahuja Angela J. Rogers Maja Artandi Linda N. Geng George A. Yendewa Debra Powell James N. Kim Brent Simmons I. Michael Goonewardene

Abstract The glycosylation of IgG plays a critical role during human severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, activating immune cells and inducing cytokine production. However, the IgM N-glycosylation has not been studied viral infection. analysis from healthy controls hospitalized disease 2019 (COVID-19) patients reveals increased high-mannose sialylation that correlates with COVID-19 severity. These trends are confirmed within SARS-CoV-2-specific...

10.1038/s41467-023-44211-0 article EN cc-by Nature Communications 2024-01-09
Hoang Van Phan Alexandra Tsitsiklis Cole Maguire Elias K. Haddad Patrice M. Becker and 95 more Seunghee Kim‐Schulze Brian Hyohyoung Lee Jing Chen Annmarie Hoch Harry Pickering Patrick van Zalm Matthew C. Altman Alison D. Augustine Carolyn S. Calfee Steve Bosinger Charles B. Cairns Walter L. Eckalbar Leying Guan Naresh Doni Jayavelu Steven H. Kleinstein Florian Krammer Holden T. Maecker Al Ozonoff Bjoern Peters Nadine Rouphael Ruth R. Montgomery Elaine F. Reed Joanna Schaenman Hanno Steen Ofer Levy Joann Diray‐Arce Charles Langelier David J. Erle Carolyn M. Hendrickson Kirsten N. Kangelaris Nguyễn Hoàng Việt Deanna Lee Suzanna Chak Rajani Ghale Ana Gonzalez Alejandra Jáuregui Carolyn Leroux Luz Torres Altamirano Ahmad Sadeed Rashid Andrew Willmore Prescott G. Woodruff Matthew F. Krummel Sidney Carrillo Alyssa Ward Ravi K. Patel Michael R. Wilson Ravi Dandekar Bonny D. Alvarenga Jayant V. Rajan Andrew Schroeder Gabriela K. Fragiadakis Eran Mick Yanedth Sanchez Guerrero Christina Love Lenka Maliskova Michael Adkisson Lauren I. R. Ehrlich Esther Melamed Justin F. Rousseau Kerin Hurley Janelle Geltman Nadia Siles Jacob E. Rogers Michele A. Kutzler Mariana Bernui Gina Cusimano Jennifer Connors Kyra Woloszczuk David Joyner Carolyn Pope Edwards Edward Lin Nataliya Melnyk Debra Powell James N. Kim I. Michael Goonewardene Brent Simmons Cecilia M. Smith Mark G. Martens Brett Croen Nicholas C. Semenza Matthew R. Bell Sara Furukawa Renee McLin George P. Tegos Brandon Rogowski Nathan Mege Kristen Ulring Steven M. Holland Lindsey B. Rosen Serena Lee Tatyana Vaysman Ana Fernandez‐Sesma Viviana Simon Harm van Bakel Ana S. González-Reiche

Age is a major risk factor for severe coronavirus disease 2019 (COVID-19), yet the mechanisms behind this relationship have remained incompletely understood. To address this, we evaluated impact of aging on host immune response in blood and upper airway, as well nasal microbiome prospective, multicenter cohort 1031 vaccine-naïve patients hospitalized COVID-19 between 18 96 years old. We performed mass cytometry, serum protein profiling, anti–severe acute respiratory syndrome 2 (SARS-CoV-2)...

10.1126/scitranslmed.adj5154 article EN mit Science Translational Medicine 2024-04-17

Current events throughout the world underscore growing threat of different forms terrorism, including radiological or nuclear attack. Pharmaceutical products and other approaches are needed to protect civilian population from radiation treat those with radiation-induced injuries. In event an attack, exposures will be heterogeneous in terms both dose quality, depending on type device used each victim's location relative source. Therefore, methods against a wide range early slowly developing...

10.1667/rr3388 article EN Radiation Research 2005-07-01

Abstract Age is a major risk factor for severe coronavirus disease-2019 (COVID-19), yet the mechanisms responsible this relationship have remained incompletely understood. To address this, we evaluated impact of aging on host and viral dynamics in prospective, multicenter cohort 1,031 patients hospitalized COVID-19, ranging from 18 to 96 years age. We performed blood transcriptomics nasal metatranscriptomics, measured peripheral immune cell populations, inflammatory protein expression,...

10.1101/2024.02.11.24301704 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2024-02-13

Chronic viral infections are ubiquitous in humans, with individuals harboring multiple latent viruses that can reactivate during acute illnesses. Recent studies have suggested SARS-CoV-2 infection lead to reactivation of such as Epstein-Barr Virus (EBV) and cytomegalovirus (CMV), yet, the extent impact COVID-19 its effect on host immune system remain incompletely understood. Here we present a comprehensive multi-omic analysis all known chronically infecting 1,154 hospitalized patients, from...

10.1101/2024.11.14.622799 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-11-16

Hospitalized COVID-19 patients exhibit diverse clinical outcomes, with some individuals diverging over time even though their initial disease severity appears similar. A systematic evaluation of molecular and cellular profiles the full course can link immune programs coordination progression heterogeneity. In this study, we carried out deep immunophenotyping conducted longitudinal multi-omics modeling integrating ten distinct assays on a total 1,152 IMPACC participants identified several...

10.1101/2023.11.03.565292 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-11-06

Abstract Hospitalized COVID-19 patients exhibit diverse immune responses during acute infection, which are associated with a wide range of clinical outcomes. However, understanding these heterogeneities and their links to various complications, especially long COVID, remains challenge. In this study, we performed unsupervised subtyping longitudinal multi-omics immunophenotyping in over 1,000 hospitalized patients, identifying two critical subtypes linked mortality or mechanical ventilation...

10.1101/2024.11.22.624784 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2024-11-25

On September 16, 2009, the National Institute of Allergy and Infectious Diseases (NIAID), part U.S. Institutes Health, convened a workshop to discuss current knowledge T- B-cell immune epitopes for members Flavivirus genus (family Flaviviridae), how this information could be used increase our basic understanding host-pathogen interactions and/or advance development new or improved vaccines diagnostics these pathogens. T-cell responses flaviviruses are critical components protective immunity...

10.1089/vim.2009.0114 article EN Viral Immunology 2010-06-01

ABSTRACT Background Better understanding of the association between characteristics patients hospitalized with coronavirus disease 2019 (COVID-19) and outcome is needed to further improve upon patient management. Methods Im muno p henotyping A ssessment in a C OVID-19 ohort (IMPACC) prospective, observational study 1,164 from 20 hospitals across United States. Disease severity was assessed using 7-point ordinal scale based on degree respiratory illness. Patients were prospectively surveyed...

10.1101/2022.07.02.22273396 preprint EN cc-by-nd medRxiv (Cold Spring Harbor Laboratory) 2022-07-05

The Cell Ontology (CL) is an OBO Foundry candidate ontology intended for the representation of cell types from all biology. A recent workshop sponsored by NIAID on hematopoietic in CL addressed issues both content and structure CL. section dealing with cells was extensively revised, plans were made restructuring these type terms as cross-products logical definitions based relationships to external ontologies, such Protein Gene Ontology. improvements this area represent a paradigm future...

10.1038/npre.2009.3543.2 preprint EN Nature Precedings 2009-08-18

Abstract The Cell Ontology (CL) aims for the representation of in vivo and vitro cell types from all biology. Although CL is a reference ontology OBO Foundry, it requires extensive revision to bring up current standards biomedical ontologies, both its structure coverage various subfields A recent workshop sponsored by NIAID on hematopoietic addressed issues. section dealing with cells was extensively revised, plans were set structuring these type terms as cross-products logical definitions...

10.1038/npre.2009.3635.1 preprint EN Nature Precedings 2009-08-19
Coming Soon ...